Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000954918 | SCV001101585 | likely benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002547257 | SCV003603626 | likely benign | Inborn genetic diseases | 2022-12-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000954918 | SCV005074401 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | GEMIN5: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV000954918 | SCV005226628 | likely benign | not provided | criteria provided, single submitter | not provided |